Document is current
Any future updates will be listed below
-
Authors
Lewis, Anna C. F. https://orcid.org/0000-0002-1274-386X
Perez, Emma F.
Prince, Anya E. R.
Flaxman, Hana R.
Gomez, Lizbeth
Brockman, Deanna G.
Chandler, Paulette D.
Kerman, Benjamin J.
Lebo, Matthew S.
Smoller, Jordan W.
Weiss, Scott T.
Blout Zawatksy, Carrie L.
Meigs, James B.
Green, Robert C.
Vassy, Jason L.
Karlson, Elizabeth W.
-
Funding
Funding for this research was provided by:
National Human Genome Research Institute (U01HG008685)
- License Information
-
More Information
Article History
Received: 20 April 2022
Accepted: 21 September 2022
First Online: 7 October 2022
Declarations
:
: Both patient and PCP interviews were judged exempt from needing ongoing Institutional Review Board (IRB) oversight by the Mass General Brigham IRB (#2020P003198), based on meeting criteria for exemption 45 CFR 46.101(b). Consent was collected verbally at the beginning of each interview. This research conformed to the principles of the Helsinki Declaration.
: Not applicable.
: ACFL owns stock in Fabric Genomics; EFP is a paid consultant for Allelica; DGB is an employee of Color Health; JWS is a member of the Scientific Advisory Board of Sensorium Therapeutics (with equity), and has received an honorarium for an internal seminar Tempus Labs. He is PI of a collaborative study of the genetics of depression and bipolar disorder sponsored by 23andMe for which 23andMe provides analysis time as in-kind support but no payments; STW receives royalties from UpToDate and is an investor in Histolix; JBM is an Academic Associate with Quest Diagnostics R&D; RCG has received compensation for advising the following companies: AIA, Allelica, Genomic Life, Genome Web, Grail, Humanity, Plumcare, OptumLabs and Verily. He is co-founder of Genome Medical. The remaining authors declare that they have no competing interests.
